The cytochrome P450 (CYP450) enzymes, heme-containing monooxygenases, are indispensable in metabolizing a broad range of drugs and other xenobiotics. Nonetheless, specific chemical entities (molecules) can inhibit these enzymes, resulting in undesirable drug-drug interactions, alterations in pharmacokinetics, and potentially compromising the efficacy and safety of drugs. Therefore, it is critical to identify molecules exhibiting inhibitory activities toward the five majors human CYP450 enzymes (1A2, 2C9, 2C19, 2D6, and 3A4) in the preliminary phases of drug development. This study presents a novel deep-learning model, MuMCyp_Net, for predicting CYP450 inhibition by small molecules. The architecture of MuMCyp_Net integrates a convolutional neural network (CNN) with an Attention mechanism, a bi-directional gated recurrent unit (biGRU) network, and a deep neural network (DNN) to efficiently process local chemical context information and global molecular properties of molecules. A total of 25,753 distinct compound molecules were utilized to train and evaluate the model’s performance. The proposed model demonstrates competitive performance as indicated by matthew’s correlation coefficients (MCC), ranging from 0.63 to 0.68, an accuracy rate between 0.82 and 0.90, and an AUC of 0.86 to 0.92. This novel approach shows considerable promise in accurately identifying CYP450 inhibitors, contributing to safer and more effective drug development. To further utilize the potential of the proposed model, a freely accessible web server tool for the virtual screening of molecules was developed, which will aid in identifying CYP450 inhibitors from non-inhibitors. The web-based tool can be accessed at https://mumcypnet.streamlit.app/.
Read full abstract